Amundi Pioneer Asset Management Inc. grew its position in shares of Cooper Companies Inc (NYSE:COO) by 2.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,252,938 shares of the medical device company’s stock after purchasing an additional 26,688 shares during the period. Cooper Companies makes up 0.9% of Amundi Pioneer Asset Management Inc.’s portfolio, making the stock its 28th biggest holding. Amundi Pioneer Asset Management Inc. owned about 2.56% of Cooper Companies worth $297,084,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Janus Henderson Group PLC grew its position in shares of Cooper Companies by 558.5% during the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock valued at $520,937,000 after purchasing an additional 1,845,368 shares in the last quarter. Pioneer Investment Management Inc. grew its position in shares of Cooper Companies by 136.6% during the 2nd quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock valued at $293,589,000 after purchasing an additional 708,028 shares in the last quarter. Koch Industries Inc. purchased a new position in Cooper Companies in the second quarter worth $312,000. Voya Investment Management LLC grew its position in Cooper Companies by 973.4% in the second quarter. Voya Investment Management LLC now owns 329,015 shares of the medical device company’s stock worth $78,773,000 after acquiring an additional 298,363 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new position in Cooper Companies in the second quarter worth $71,050,000. Hedge funds and other institutional investors own 95.23% of the company’s stock.

Shares of Cooper Companies Inc (COO) opened at $242.29 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. The firm has a market cap of $11,860.00, a price-to-earnings ratio of 25.91, a price-to-earnings-growth ratio of 2.08 and a beta of 0.55. Cooper Companies Inc has a one year low of $158.73 and a one year high of $256.39.

Cooper Companies (NYSE:COO) last posted its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, topping the consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million during the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies had a net margin of 16.45% and a return on equity of 16.00%. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.30 earnings per share. equities analysts anticipate that Cooper Companies Inc will post 9.72 EPS for the current fiscal year.

Several brokerages recently issued reports on COO. Stifel Nicolaus upped their target price on shares of Cooper Companies from $265.00 to $275.00 and gave the stock a “buy” rating in a research report on Tuesday, September 12th. J P Morgan Chase & Co reiterated a “hold” rating and issued a $235.00 target price on shares of Cooper Companies in a research report on Tuesday, September 12th. Robert W. Baird reiterated a “buy” rating and issued a $273.00 target price (up from $267.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Oppenheimer Holdings, Inc. reiterated a “hold” rating and issued a $250.00 target price on shares of Cooper Companies in a research report on Tuesday, September 12th. Finally, Stephens reiterated an “equal weight” rating and issued a $250.00 target price (up from $235.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Cooper Companies has an average rating of “Buy” and a consensus price target of $260.22.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Cooper Companies Inc (COO) Stake Lifted by Amundi Pioneer Asset Management Inc.” was reported by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.watchlistnews.com/cooper-companies-inc-coo-stake-lifted-by-amundi-pioneer-asset-management-inc/1728826.html.

Cooper Companies Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.